NEW YORK (GenomeWeb News) – What were the articles that gained the most interest from GenomeWeb Daily News' readers last week? Here are the top five:
1) USPTO Appeals Board Invalidates Claims on Illumina Patent Included in Qiagen-IBS Litigation
2) BioFire Defense Receives Emergency Use Authorization for Two FilmArray Ebola Tests
3) Clontech Licenses CRISPR-Cas9 Technology from Broad Institute
4) Ventana, ImmunoGen Team up in CDx Deal
5) Qiagen Inks CDx Deal with Astellas Pharma